ZIOPTAN 0.0015 % Ophthalmic Solution
RxNorm 1244616
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1244616 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: ZIOPTAN 0.0015 % Ophthalmic Solution.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBDPrescribable
Semantic Branded Drug (SBD):
Tafluprost 0.015 mg/ML Ophthalmic Solution [Zioptan]
(Atom ID: 4247497)
PSNPrescribable
Prescribable Name (PSN):
ZIOPTAN 0.0015 % Ophthalmic Solution
(Atom ID: 6401198)
SYPrescribable
Synonym (SY):
Zioptan 0.0015 % Ophthalmic Solution
(Atom ID: 4247499)
SYPrescribable
Synonym (SY):
Zioptan 0.0045 mg in 0.3 mL Ophthalmic Solution
(Atom ID: 6814306)
SYPrescribable
Synonym (SY):
Zioptan 0.015 mg/ML Ophthalmic Solution
(Atom ID: 4247498)
Patient Education
Tafluprost Ophthalmic
Tafluprost ophthalmic is used to treat glaucoma (a condition in which increased pressure in the eye can lead to gradual loss of vision) and ocular hypertension (a condition which causes increased pressure in the eye). Tafluprost is in a class of medications called prostaglandin analogs. It lowers pressure in the eye by increasing the flow of natural eye fluids out of the eye.
[Learn More]
* Please review the disclaimer below.